| Literature DB >> 32867822 |
Kwadwo Owusu Akuffo1, Akosua Kesewah Asare2, Ronel Sewpaul3, Natisha Dukhi3, David Ben Kumah2, Eldad Agyei-Manu2,4, Emmanuel Kofi Addo2,5,6, Priscilla Reddy3,7.
Abstract
OBJECTIVE: Diabetes is a chronic disease of uncontrolled blood sugar levels. People with diabetes are at an increased risk of developing visual impairment and other diabetes-related visual complications. The study aims to determine the eyecare utilization pattern and its associated determinants among diabetics in the South African National Health and Nutrition Examination Survey (SANHANES-1).Entities:
Keywords: Barriers; Diabetes; Disparities; Eye Care Services; Eye care utilization; High-risk; Population-based; Sociodemographic characteristics; South Africa
Mesh:
Year: 2020 PMID: 32867822 PMCID: PMC7457475 DOI: 10.1186/s13104-020-05245-5
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Description of the analytic sample
| % | Frequency | |
|---|---|---|
| Total | 100.0 | 325 |
| Age (mean, S.D.) | 57.3 | 13.3 |
| 15–44 | 12.6 | 41 |
| 45–54 | 28.3 | 92 |
| 55–64 | 33.2 | 108 |
| ≥ 65 | 25.8 | 84 |
| Sex | ||
| Males | 31.4 | 102 |
| Females | 68.6 | 223 |
| Ethnicity | ||
| African | 62.5 | 203 |
| White | 2.2 | 7 |
| ’Coloured’(mixed race) | 23.1 | 75 |
| Indian | 12.3 | 40 |
| High risk alcohol use | 11.7 | 38 |
| Current smoker | 14.5 | 47 |
| Body mass index (BMI) (kg/m2) (mean, S.D.) | 30.6 | 7.3 |
| Underweight < 18.5 kg/m2 | 3.4 | 11 |
| Normal weight 18.5–24.9 kg/m2 | 17.8 | 58 |
| Overweight 25–29.9 kg/m2 | 26.5 | 86 |
| Obese ≥ 30 kg/m2 | 52.3 | 170 |
| Residence | ||
| Rural | 32.3 | 105 |
| Urban | 67.7 | 220 |
| Has health insurance | 17.5 | 57 |
| Hypertensive | 77.5 | 252 |
| High cholesterol | 23.4 | 76 |
| Cardiovascular disease | 20.0 | 65 |
| Accessed health care in past 5 years | 56.3 | 183 |
| Clinician-assessed vision loss | 29.8 | 97 |
| Self-reported vision problems | 43.4 | 141 |
| Diabetic medication use | ||
| No medication | 16.3 | 53 |
| Oral glycaemic medication | 54.8 | 178 |
| Insulin | 3.7 | 12 |
| Insulin and oral glycaemic medication | 25.2 | 82 |
| Number of years since diabetes diagnosis (mean, S.D.) | 12.7 | 15.9 |
| 0–5 years | 45.5 | 148 |
| 6–10 years | 15.4 | 50 |
| 11–20 years | 19.4 | 63 |
| > 20 years | 19.7 | 64 |
Prevalence of having ever had an eye examination since diabetes diagnosis
| Had an eye examination since diabetes diagnosis | ||||
|---|---|---|---|---|
| % | 95% CI | n | p value | |
| Overall | 49.0 | [41.4–56.6] | 325 | |
| Predisposing factors | ||||
| Age | ||||
| 15–44 years | 31.0 | [16.3–50.8] | 41 | 0.024 |
| 45–54 years | 42.6 | [30.4–55.7] | 92 | |
| 55–64 years | 59.6 | [47.3–70.7] | 108 | |
| ≥ 65 years | 59.6 | [45.3–72.4] | 84 | |
| Sex | ||||
| Males | 50.0 | [37.5–62.4] | 102 | 0.857 |
| Females | 48.5 | [39.3–57.8] | 223 | |
| Ethnicity | ||||
| African | 49.1 | [40.1–58.1] | 203 | 0.678 |
| ’Coloured’(mixed race) | 53.1 | [38.8–67.0] | 75 | |
| White or Indian | 41.6 | [24.4–61.2] | 47 | |
| High risk alcohol use | ||||
| Low risk | 49.0 | [40.9–57.2] | 287 | 0.996 |
| High risk | 48.9 | [24.9–73.4] | 38 | |
| Current smoker | ||||
| No | 50.8 | [42.9–58.6] | 278 | 0.257 |
| Yes | 37.5 | [19.6–59.5] | 47 | |
| Body mass index (BMI) | ||||
| Underweight/normal weight: < 25 kg/m2 | 46.5 | [31.5–62.1] | 69 | 0.764 |
| Overweight: 25–29.9 kg/m2 | 45.9 | [32.7–59.7] | 86 | |
| Obese: ≥30 kg/m2 | 51.5 | [41.1–61.8] | 170 | |
| Enabling factors | ||||
| Residence | ||||
| Rural | 45.9 | [34.4–57.9] | 105 | 0.525 |
| Urban | 51.0 | [41.2–60.7] | 220 | |
| Has health insurance | ||||
| No | 43.8 | [35.5–52.4] | 268 | 0.003 |
| Yes | 72.0 | [55.2–84.3] | 57 | |
| Need factors | ||||
| Hypertension | ||||
| No | 36.6 | [24.5–50.6] | 73 | 0.034 |
| Yes | 53.7 | [45.2–62.0] | 252 | |
| High cholesterol | ||||
| No | 50.9 | [42.3–59.4] | 249 | 0.333 |
| Yes | 42.9 | [29.8–57.1] | 76 | |
| Cardiovascular disease | ||||
| No | 46.9 | [38.8–55.2] | 260 | 0.21 |
| Yes | 58.0 | [42.0–72.4] | 65 | |
| Accessed health care in past 5 years | ||||
| No | 47.2 | [37.1–57.5] | 142 | 0.658 |
| Yes | 50.4 | [40.1–60.6] | 183 | |
| Clinician-assessed vision loss | ||||
| No | 44.8 | [36.0–53.8] | 228 | 0.06 |
| Yes | 59.1 | [46.4–70.7] | 97 | |
| Self-reported vision problems | ||||
| No | 47.4 | [37.2–57.8] | 184 | 0.628 |
| Yes | 51.2 | [40.2–62.1] | 141 | |
| Diabetic medication use | ||||
| No medication | 35.2 | [20.8–53.0] | 53 | 0.056 |
| Oral glycaemic medication | 46.6 | [36.2–57.3] | 178 | |
| Insulin | 64.3 | [20.7–92.6] | 12 | |
| Insulin and oral glycaemic medication | 66.9 | [54.1–77.6] | 82 | |
| Years since diabetes diagnosis | ||||
| 0–5 years | 33.0 | [23.9–43.5] | 148 | < 0.001 |
| 6–10 years | 68.2 | [50.4–81.9] | 50 | |
| 11–20 years | 66.0 | [49.3–79.5] | 63 | |
| > 20 years | 64.4 | [48.8–77.4] | 64 | |
OR, odds ratio; CI, confidence interval; n, number of participants; ref, reference group
Multiple logistic regression of having an eye examination since diabetes diagnosis and related factors
| Model 1 | Model 2 | Model 3 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI (OR) | p-value | OR | 95% CI (OR) | p-value | OR | 95% CI (OR) | p-value | |
| Predisposing factors | |||||||||
| Age | |||||||||
| 15–44 years | ref | – | – | ref | – | – | ref | – | – |
| 45–54 years | 1.82 | [0.66–5.00] | 0.243 | 1.62 | [0.6–4.35] | 0.338 | 2.00 | [0.77–5.21] | 0.154 |
| 55–64 years | 3.77 | [1.45–9.77] | 0.007 * | 4.58 | [1.89–11.06] | 0.001 * | 4.18 | [1.63–10.72] | 0.003 * |
| ≥ 65 years | 3.68 | [1.35–10.02] | 0.011 * | 5.90 | [2.2–15.82] | <0.001 * | 4.78 | [1.75–13.05] | 0.002 * |
| Sex | |||||||||
| Males | ref | – | – | ref | – | – | ref | – | – |
| Females | 0.81 | [0.41–1.6] | 0.546 | 0.89 | [0.43–1.84] | 0.753 | 0.95 | [0.45–2.02] | 0.897 |
| Ethnicity | |||||||||
| African | ref | – | – | ref | – | – | ref | – | – |
| ’Coloured’(mixed race) | 1.71 | [0.75–3.92] | 0.204 | 1.91 | [0.75–4.87] | 0.173 | 1.91 | [0.72–5.07] | 0.192 |
| White or Indian | 0.65 | [0.28–1.48] | 0.299 | 0.29 | [0.09–0.98] | 0.046 * | 0.30 | [0.09–1.05] | 0.060 |
| High risk alcohol use | 1.29 | [0.35–4.76] | 0.698 | 0.98 | [0.27–3.51] | 0.973 | 1.50 | [0.43–5.29] | 0.523 |
| Current smoker | 0.50 | [0.19–1.31] | 0.155 | 0.45 | [0.17–1.24] | 0.123 | 0.39 | [0.15–1.04] | 0.060 |
| Body mass index (BMI) | |||||||||
| Underweight/normal weight: < 25 kg/m2 | ref | – | – | ref | – | – | ref | – | – |
| Overweight: 25–29.9 kg/m2 | 0.74 | [0.32–1.68] | 0.467 | 0.40 | [0.17–0.96] | 0.041 * | 0.38 | [0.15–0.93] | 0.034 * |
| Obese: ≥ 30 kg/m2 | 1.05 | [0.47–2.35] | 0.907 | 0.75 | [0.33–1.72] | 0.495 | 0.77 | [0.32–1.85] | 0.563 |
| Enabling factors | |||||||||
| Residence | |||||||||
| Rural | ref | – | – | ref | – | – | |||
| Urban | 1.44 | [0.74–2.82] | 0.283 | 1.41 | [0.68–2.91] | 0.355 | |||
| Has health insurance | 6.98 | [2.69–18.15] | <0.001 * | 6.32 | [2.00–19.91] | 0.002 * | |||
| Need factors | |||||||||
| Hypertensive | 1.06 | [0.54–2.08] | 0.868 | ||||||
| High cholesterol | 0.64 | [0.3–1.38] | 0.253 | ||||||
| Cardiovascular disease | 1.33 | [0.6–2.94] | 0.479 | ||||||
| Accessed health care in past 5 years | 0.98 | [0.52–1.85] | 0.949 | ||||||
| Clinician assessed vision loss | 1.97 | [0.83–4.69] | 0.125 | ||||||
| Self–reported vision problems | 0.52 | [0.24–1.15] | 0.106 | ||||||
| Diabetic medication use | |||||||||
| No medication | ref | – | – | ||||||
| Oral glycaemic medication | 0.99 | [0.39–2.48] | 0.977 | ||||||
| Insulin | 2.67 | [0.47–15.2] | 0.267 | ||||||
| Insulin and oral glycaemic medication | 2.57 | [0.9–7.35] | 0.077 | ||||||
| Number of years since diabetes diagnosis | |||||||||
| 0–5 years | ref | – | – | ||||||
| 6–10 years | 4.23 | [1.55–11.54] | 0.005 * | ||||||
| 11–20 years | 2.72 | [0.99–7.43] | 0.052 | ||||||
| > 20 years | 2.38 | [0.91–6.2] | 0.076 | ||||||
OR, Odds ratio; CI, confidence interval; n, number of participants; ref, reference group; *, statistically significant p values (p < 0.05)